+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Rotary-Cutting Biopsy System for Breast Lesion Market - Global Forecast 2026-2032- Product Image
Rotary-Cutting Biopsy System for Breast Lesion Market - Global Forecast 2026-2032- Product Image
Sale

Rotary-Cutting Biopsy System for Breast Lesion Market - Global Forecast 2026-2032

  • Report

  • 180 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6081366
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Rotary-Cutting Biopsy System for Breast Lesion Market is projected to reach USD 1.05 Billion in 2026. It is expected to continue growing at a CAGR of 10.09%, reaching USD 1.87 Billion by 2032.

Rotary-Cutting Biopsy Systems Support More Precise Breast Lesion Evaluation

Rotary-cutting biopsy systems are used to obtain multiple tissue samples from breast lesions through a minimally invasive approach. Their clinical value is linked to reliable sampling, compatibility with image guidance, procedural efficiency, and the ability to reduce the need for open surgical biopsy in appropriate cases. Adoption is shaped by diagnostic protocols, imaging infrastructure, reimbursement conditions, clinician training, and patient preference for less invasive evaluation.

Image-Guided Diagnosis and Workflow Efficiency Are Reshaping Adoption

The landscape is shifting toward image-guided, outpatient diagnostic pathways that emphasize accurate lesion targeting, standardized specimen handling, and shorter recovery. Improvements in device ergonomics, vacuum assistance, sampling control, and integration with ultrasound, stereotactic, or magnetic-resonance guidance are influencing purchasing and clinical practice. At the same time, healthcare providers are paying closer attention to infection prevention, tissue adequacy, procedure-related discomfort, and the consistency of results across operators and care settings.

Artificial Intelligence Strengthens Targeting, Triage, and Quality Assurance

Artificial intelligence is increasingly relevant across the breast biopsy pathway, particularly for image interpretation, lesion classification, targeting support, and workflow prioritization. When appropriately validated, AI can help identify suspicious findings, support radiologist review, and improve consistency in selecting lesions for tissue sampling. Its cumulative effect depends on high-quality local data, transparent performance evaluation, interoperability with imaging systems, cybersecurity, and continued clinician oversight; AI is an aid to decision-making rather than a substitute for pathology or professional judgment.

Regional Conditions Create Uneven but Expanding Opportunities for Modern Biopsy Workflows

North America benefits from established breast-imaging networks, specialized clinicians, and broader access to image-guided procedures, while reimbursement and procurement requirements remain important adoption considerations. Europe combines mature diagnostic services with strong emphasis on clinical evidence, patient safety, and health-technology assessment. Asia-Pacific presents diverse conditions: advanced systems coexist with rapidly developing diagnostic capacity, urban concentration of services, and persistent access gaps. Latin America is influenced by uneven screening coverage, private-sector investment, and differences in specialist availability. The Middle East is seeing continued development of tertiary-care and diagnostic infrastructure, particularly in major urban centers. Africa remains highly heterogeneous, with adoption constrained in many settings by equipment access, workforce shortages, referral delays, and affordability, although targeted investments in breast-health services can improve reach.

Economic and Security Alliances Shape Procurement, Standards, and Access

ASEAN markets are characterized by varied healthcare financing, growing urban diagnostic capacity, and cross-border differences in specialist training and device regulation. BRICS economies combine substantial clinical demand with diverse public and private delivery models, local manufacturing priorities, and uneven access between metropolitan and rural areas. The European Union emphasizes harmonized safety and regulatory expectations alongside national reimbursement decisions. G7 countries generally have mature imaging and pathology infrastructure but face pressures related to cost control, aging populations, and workforce efficiency. GCC countries continue to strengthen specialist and hospital-based diagnostic services, with procurement often concentrated among major institutions. NATO members span highly developed and transitional healthcare systems, making interoperability, supply resilience, and common quality principles important considerations.

Country-Level Adoption Reflects Infrastructure, Regulation, and Clinical Capacity

Australia and Canada have established breast-imaging services but must address geographic dispersion and equitable access. Brazil and Mexico show strong potential in leading urban centers, alongside persistent regional disparities in screening and specialist availability. China, India, Japan, and South Korea combine significant clinical infrastructure with distinct regulatory, reimbursement, and procurement environments; Japan emphasizes mature, quality-focused care pathways, while China and India also face substantial variation between urban and rural services. France, Germany, Italy, Spain, and the United Kingdom operate within advanced diagnostic systems, with adoption influenced by hospital purchasing, clinical guidelines, staffing, and health-system budget priorities. Russia’s access landscape is shaped by regional infrastructure, public-sector capacity, and procurement conditions. In the United States, broad use of image-guided breast diagnostics is supported by specialized providers and advanced facilities, while reimbursement, compliance, documentation, and cost-effectiveness remain central to purchasing decisions.

Leaders Should Prioritize Evidence, Interoperability, and Equitable Clinical Deployment

Industry leaders should build adoption around clinically relevant evidence demonstrating tissue adequacy, safety, workflow value, and reproducibility across imaging modalities and operator settings. Products should support intuitive handling, efficient specimen management, and integration with existing imaging, pathology, and documentation systems. Training programs should be adapted to local competency requirements and include quality monitoring after implementation. Organizations should also map reimbursement and regulatory pathways by country, maintain resilient supply and service networks, protect patient data in AI-enabled workflows, and design deployment models that extend diagnostic capability beyond major urban hospitals.

Research Methodology Combines Structured Market Review With Clinical and System-Level Analysis

This executive summary uses the defined market scope of rotary-cutting biopsy systems for breast lesions and organizes findings across technology, clinical workflow, regulation, infrastructure, and healthcare-access factors. The assessment framework compares regional, economic-group, and country-level conditions without presenting market estimates, market shares, or forecasts. Insights are derived from established relationships between image-guided breast diagnosis, device functionality, provider capability, reimbursement, procurement, and patient-safety requirements; conclusions should be interpreted alongside current clinical guidance, regulatory documentation, and local health-system evidence.

Reliable Sampling and Integrated Care Pathways Will Define Long-Term Relevance

Rotary-cutting biopsy systems occupy an important role in minimally invasive breast-lesion diagnosis, particularly where accurate sampling and efficient image-guided workflows are priorities. Future progress will depend less on device availability alone and more on coordinated improvements in imaging quality, pathology integration, clinician training, reimbursement, data governance, and equitable access. Providers and suppliers that combine dependable procedural performance with evidence-based implementation and responsible digital support will be best positioned to strengthen diagnostic quality across diverse healthcare environments.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Rotary-Cutting Biopsy System for Breast Lesion Market, by Guidance Technique
7.1. Introduction
7.2. Ct
7.3. Mri
7.4. Stereotactic
7.4.1. Automated Stereotactic
7.4.2. Manual Stereotactic
7.5. Ultrasound
7.5.1. Portable Ultrasound
7.5.2. Stationary Ultrasound
8. Rotary-Cutting Biopsy System for Breast Lesion Market, by Product Type
8.1. Introduction
8.2. Disposable Blades
8.3. Reusable Handles
9. Rotary-Cutting Biopsy System for Breast Lesion Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.2.1. Clinic Based Ambulatory Surgical Centers
9.2.2. Standalone Ambulatory Surgical Centers
9.3. Diagnostic Centers
9.3.1. Hospital Affiliated Diagnostic Centers
9.3.2. Standalone Diagnostic Centers
9.4. Hospitals
9.4.1. Private Hospitals
9.4.2. Public Hospitals
10. Rotary-Cutting Biopsy System for Breast Lesion Market, by Lesion Type
10.1. Introduction
10.2. Cystic Lesions
10.3. Microcalcifications
10.4. Non Palpable Lesions
10.5. Palpable Lesions
11. Rotary-Cutting Biopsy System for Breast Lesion Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Rotary-Cutting Biopsy System for Breast Lesion Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Rotary-Cutting Biopsy System for Breast Lesion Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Argon Medical Devices Inc.
15.2. B Braun Melsungen AG
15.3. Becton Dickinson and Company
15.4. Biocept Inc.
15.5. Cardinal Health Inc.
15.6. Chongqing Xishan Science & Technology Co Ltd
15.7. Cook Medical LLC
15.8. Cultiva Medical
15.9. Danaher Corporation
15.10. Devicor Medical Products Inc.
15.11. Hologic Inc.
15.12. Intact Medical Corporation
15.13. IZI Medical Products LLC
15.14. Medtronic plc
15.15. Merit Medical Systems Inc.
15.16. Planmed Oy
15.17. Scion Medical Technologies LLC
15.18. Sterylab Srl
15.19. Stryker Corporation
15.20. ZAMAR CARE Srl
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Rotary-Cutting Biopsy System for Breast Lesion Market, Years Considered for the Study
FIGURE 2. Global Rotary-Cutting Biopsy System for Breast Lesion Market, Research Design
FIGURE 3. Global Rotary-Cutting Biopsy System for Breast Lesion Market, Research Framework
FIGURE 4. Global Rotary-Cutting Biopsy System for Breast Lesion Market, Data Triangulation
FIGURE 5. Global Rotary-Cutting Biopsy System for Breast Lesion Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Guidance Technique, 2025 vs 2032 (%)
FIGURE 7. Global Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Guidance Technique, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 9. Global Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Rotary-Cutting Biopsy System for Breast Lesion Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Rotary-Cutting Biopsy System for Breast Lesion Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Lesion Type, 2025 vs 2032 (%)
FIGURE 13. Global Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Lesion Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Rotary-Cutting Biopsy System for Breast Lesion Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Rotary-Cutting Biopsy System for Breast Lesion Market Segmentation & Coverage
TABLE 2. Global Rotary-Cutting Biopsy System for Breast Lesion Market Size, 2017-2032 (USD Million)
TABLE 3. Global Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Guidance Technique, 2017-2032 (USD Million)
TABLE 4. Global Ct Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Ct Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Ct Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Mri Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Mri Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Mri Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Stereotactic Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Stereotactic Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Stereotactic Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Automated Stereotactic Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Automated Stereotactic Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Automated Stereotactic Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Manual Stereotactic Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Manual Stereotactic Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Manual Stereotactic Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Ultrasound Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Ultrasound Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Ultrasound Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Portable Ultrasound Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Portable Ultrasound Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Portable Ultrasound Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Stationary Ultrasound Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Stationary Ultrasound Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Stationary Ultrasound Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 29. Global Disposable Blades Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Disposable Blades Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Disposable Blades Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Reusable Handles Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Reusable Handles Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Reusable Handles Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Rotary-Cutting Biopsy System for Breast Lesion Market Size, by End User, 2017-2032 (USD Million)
TABLE 36. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Clinic Based Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Clinic Based Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Clinic Based Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Standalone Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Standalone Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Standalone Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Hospital Affiliated Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Hospital Affiliated Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Hospital Affiliated Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Standalone Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Standalone Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Standalone Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Public Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Public Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Public Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 64. Global Cystic Lesions Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Cystic Lesions Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Cystic Lesions Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Microcalcifications Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Microcalcifications Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Microcalcifications Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Non Palpable Lesions Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Non Palpable Lesions Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Non Palpable Lesions Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Palpable Lesions Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Palpable Lesions Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Palpable Lesions Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Guidance Technique, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Stereotactic, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ultrasound, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Rotary-Cutting Biopsy System for Breast Lesion Market Size, by End User, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 87. North America Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. North America Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Guidance Technique, 2017-2032 (USD Million)
TABLE 89. North America Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Stereotactic, 2017-2032 (USD Million)
TABLE 90. North America Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ultrasound, 2017-2032 (USD Million)
TABLE 91. North America Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 92. North America Rotary-Cutting Biopsy System for Breast Lesion Market Size, by End User, 2017-2032 (USD Million)
TABLE 93. North America Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 94. North America Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 95. North America Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 96. North America Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 97. Latin America Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Latin America Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Guidance Technique, 2017-2032 (USD Million)
TABLE 99. Latin America Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Stereotactic, 2017-2032 (USD Million)
TABLE 100. Latin America Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ultrasound, 2017-2032 (USD Million)
TABLE 101. Latin America Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 102. Latin America Rotary-Cutting Biopsy System for Breast Lesion Market Size, by End User, 2017-2032 (USD Million)
TABLE 103. Latin America Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 104. Latin America Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 105. Latin America Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 106. Latin America Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 107. Europe Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Europe Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Guidance Technique, 2017-2032 (USD Million)
TABLE 109. Europe Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Stereotactic, 2017-2032 (USD Million)
TABLE 110. Europe Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ultrasound, 2017-2032 (USD Million)
TABLE 111. Europe Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 112. Europe Rotary-Cutting Biopsy System for Breast Lesion Market Size, by End User, 2017-2032 (USD Million)
TABLE 113. Europe Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 114. Europe Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 115. Europe Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 116. Europe Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 117. Middle East Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Middle East Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Guidance Technique, 2017-2032 (USD Million)
TABLE 119. Middle East Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Stereotactic, 2017-2032 (USD Million)
TABLE 120. Middle East Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ultrasound, 2017-2032 (USD Million)
TABLE 121. Middle East Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 122. Middle East Rotary-Cutting Biopsy System for Breast Lesion Market Size, by End User, 2017-2032 (USD Million)
TABLE 123. Middle East Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 124. Middle East Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 125. Middle East Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 126. Middle East Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 127. Africa Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Africa Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Guidance Technique, 2017-2032 (USD Million)
TABLE 129. Africa Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Stereotactic, 2017-2032 (USD Million)
TABLE 130. Africa Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ultrasound, 2017-2032 (USD Million)
TABLE 131. Africa Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 132. Africa Rotary-Cutting Biopsy System for Breast Lesion Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. Africa Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 134. Africa Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 135. Africa Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 136. Africa Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 137. Global Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. ASEAN Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. ASEAN Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Guidance Technique, 2017-2032 (USD Million)
TABLE 140. ASEAN Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Stereotactic, 2017-2032 (USD Million)
TABLE 141. ASEAN Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ultrasound, 2017-2032 (USD Million)
TABLE 142. ASEAN Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 143. ASEAN Rotary-Cutting Biopsy System for Breast Lesion Market Size, by End User, 2017-2032 (USD Million)
TABLE 144. ASEAN Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 145. ASEAN Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 146. ASEAN Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 147. ASEAN Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 148. GCC Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. GCC Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Guidance Technique, 2017-2032 (USD Million)
TABLE 150. GCC Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Stereotactic, 2017-2032 (USD Million)
TABLE 151. GCC Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ultrasound, 2017-2032 (USD Million)
TABLE 152. GCC Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 153. GCC Rotary-Cutting Biopsy System for Breast Lesion Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. GCC Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 155. GCC Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 156. GCC Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 157. GCC Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 158. European Union Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Group, 2017-2032 (USD Million)
TABLE 159. European Union Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Guidance Technique, 2017-2032 (USD Million)
TABLE 160. European Union Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Stereotactic, 2017-2032 (USD Million)
TABLE 161. European Union Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ultrasound, 2017-2032 (USD Million)
TABLE 162. European Union Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 163. European Union Rotary-Cutting Biopsy System for Breast Lesion Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. European Union Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 165. European Union Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 166. European Union Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 167. European Union Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 168. BRICS Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Group, 2017-2032 (USD Million)
TABLE 169. BRICS Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Guidance Technique, 2017-2032 (USD Million)
TABLE 170. BRICS Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Stereotactic, 2017-2032 (USD Million)
TABLE 171. BRICS Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ultrasound, 2017-2032 (USD Million)
TABLE 172. BRICS Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 173. BRICS Rotary-Cutting Biopsy System for Breast Lesion Market Size, by End User, 2017-2032 (USD Million)
TABLE 174. BRICS Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 175. BRICS Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 176. BRICS Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 177. BRICS Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 178. G7 Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Group, 2017-2032 (USD Million)
TABLE 179. G7 Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Guidance Technique, 2017-2032 (USD Million)
TABLE 180. G7 Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Stereotactic, 2017-2032 (USD Million)
TABLE 181. G7 Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ultrasound, 2017-2032 (USD Million)
TABLE 182. G7 Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 183. G7 Rotary-Cutting Biopsy System for Breast Lesion Market Size, by End User, 2017-2032 (USD Million)
TABLE 184. G7 Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 185. G7 Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 186. G7 Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 187. G7 Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 188. NATO Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Group, 2017-2032 (USD Million)
TABLE 189. NATO Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Guidance Technique, 2017-2032 (USD Million)
TABLE 190. NATO Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Stereotactic, 2017-2032 (USD Million)
TABLE 191. NATO Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ultrasound, 2017-2032 (USD Million)
TABLE 192. NATO Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 193. NATO Rotary-Cutting Biopsy System for Breast Lesion Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. NATO Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 195. NATO Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 196. NATO Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 197. NATO Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 198. Global Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Country, 2017-2032 (USD Million)
TABLE 199. United States Rotary-Cutting Biopsy System for Breast Lesion Market Size, 2017-2032 (USD Million)
TABLE 200. United States Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Guidance Technique, 2017-2032 (USD Million)
TABLE 201. United States Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Stereotactic, 2017-2032 (USD Million)
TABLE 202. United States Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ultrasound, 2017-2032 (USD Million)
TABLE 203. United States Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 204. United States Rotary-Cutting Biopsy System for Breast Lesion Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. United States Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 206. United States Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 207. United States Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 208. United States Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 209. Canada Rotary-Cutting Biopsy System for Breast Lesion Market Size, 2017-2032 (USD Million)
TABLE 210. Canada Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Guidance Technique, 2017-2032 (USD Million)
TABLE 211. Canada Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Stereotactic, 2017-2032 (USD Million)
TABLE 212. Canada Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ultrasound, 2017-2032 (USD Million)
TABLE 213. Canada Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 214. Canada Rotary-Cutting Biopsy System for Breast Lesion Market Size, by End User, 2017-2032 (USD Million)
TABLE 215. Canada Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 216. Canada Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 217. Canada Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 218. Canada Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 219. Mexico Rotary-Cutting Biopsy System for Breast Lesion Market Size, 2017-2032 (USD Million)
TABLE 220. Mexico Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Guidance Technique, 2017-2032 (USD Million)
TABLE 221. Mexico Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Stereotactic, 2017-2032 (USD Million)
TABLE 222. Mexico Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ultrasound, 2017-2032 (USD Million)
TABLE 223. Mexico Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 224. Mexico Rotary-Cutting Biopsy System for Breast Lesion Market Size, by End User, 2017-2032 (USD Million)
TABLE 225. Mexico Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 226. Mexico Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 227. Mexico Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 228. Mexico Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 229. Brazil Rotary-Cutting Biopsy System for Breast Lesion Market Size, 2017-2032 (USD Million)
TABLE 230. Brazil Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Guidance Technique, 2017-2032 (USD Million)
TABLE 231. Brazil Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Stereotactic, 2017-2032 (USD Million)
TABLE 232. Brazil Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ultrasound, 2017-2032 (USD Million)
TABLE 233. Brazil Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 234. Brazil Rotary-Cutting Biopsy System for Breast Lesion Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. Brazil Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 236. Brazil Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 237. Brazil Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 238. Brazil Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 239. United Kingdom Rotary-Cutting Biopsy System for Breast Lesion Market Size, 2017-2032 (USD Million)
TABLE 240. United Kingdom Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Guidance Technique, 2017-2032 (USD Million)
TABLE 241. United Kingdom Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Stereotactic, 2017-2032 (USD Million)
TABLE 242. United Kingdom Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ultrasound, 2017-2032 (USD Million)
TABLE 243. United Kingdom Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 244. United Kingdom Rotary-Cutting Biopsy System for Breast Lesion Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. United Kingdom Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 246. United Kingdom Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 247. United Kingdom Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 248. United Kingdom Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 249. Germany Rotary-Cutting Biopsy System for Breast Lesion Market Size, 2017-2032 (USD Million)
TABLE 250. Germany Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Guidance Technique, 2017-2032 (USD Million)
TABLE 251. Germany Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Stereotactic, 2017-2032 (USD Million)
TABLE 252. Germany Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ultrasound, 2017-2032 (USD Million)
TABLE 253. Germany Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 254. Germany Rotary-Cutting Biopsy System for Breast Lesion Market Size, by End User, 2017-2032 (USD Million)
TABLE 255. Germany Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 256. Germany Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 257. Germany Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 258. Germany Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 259. France Rotary-Cutting Biopsy System for Breast Lesion Market Size, 2017-2032 (USD Million)
TABLE 260. France Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Guidance Technique, 2017-2032 (USD Million)
TABLE 261. France Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Stereotactic, 2017-2032 (USD Million)
TABLE 262. France Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ultrasound, 2017-2032 (USD Million)
TABLE 263. France Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 264. France Rotary-Cutting Biopsy System for Breast Lesion Market Size, by End User, 2017-2032 (USD Million)
TABLE 265. France Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 266. France Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 267. France Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 268. France Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 269. Russia Rotary-Cutting Biopsy System for Breast Lesion Market Size, 2017-2032 (USD Million)
TABLE 270. Russia Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Guidance Technique, 2017-2032 (USD Million)
TABLE 271. Russia Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Stereotactic, 2017-2032 (USD Million)
TABLE 272. Russia Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ultrasound, 2017-2032 (USD Million)
TABLE 273. Russia Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 274. Russia Rotary-Cutting Biopsy System for Breast Lesion Market Size, by End User, 2017-2032 (USD Million)
TABLE 275. Russia Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 276. Russia Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 277. Russia Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 278. Russia Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 279. Italy Rotary-Cutting Biopsy System for Breast Lesion Market Size, 2017-2032 (USD Million)
TABLE 280. Italy Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Guidance Technique, 2017-2032 (USD Million)
TABLE 281. Italy Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Stereotactic, 2017-2032 (USD Million)
TABLE 282. Italy Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ultrasound, 2017-2032 (USD Million)
TABLE 283. Italy Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 284. Italy Rotary-Cutting Biopsy System for Breast Lesion Market Size, by End User, 2017-2032 (USD Million)
TABLE 285. Italy Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 286. Italy Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 287. Italy Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 288. Italy Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 289. Spain Rotary-Cutting Biopsy System for Breast Lesion Market Size, 2017-2032 (USD Million)
TABLE 290. Spain Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Guidance Technique, 2017-2032 (USD Million)
TABLE 291. Spain Rotary-Cutting Biopsy System for Breast Lesion Market Size, by Stereotactic, 2017-2032 (USD Million)
TABLE 292. Spain Rotary-Cutting Biopsy System for Breast Lesion Market Size, by U

Companies Mentioned

  • Argon Medical Devices Inc.
  • B Braun Melsungen AG
  • Becton Dickinson and Company
  • Biocept Inc.
  • Cardinal Health Inc.
  • Chongqing Xishan Science & Technology Co Ltd
  • Cook Medical LLC
  • Cultiva Medical
  • Danaher Corporation
  • Devicor Medical Products Inc.
  • Hologic Inc.
  • Intact Medical Corporation
  • IZI Medical Products LLC
  • Medtronic plc
  • Merit Medical Systems Inc.
  • Planmed Oy
  • Scion Medical Technologies LLC
  • Sterylab Srl
  • Stryker Corporation
  • ZAMAR CARE Srl

Related Topics

Related Reports

Cutting Biopsy System for Breast Lesion Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Cutting Biopsy System for Breast Lesion Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Breast Cancer Screening Device Market - Global Forecast 2026-2032 - Product Image

Breast Cancer Screening Device Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Breast Cancer Diagnostics Market - Strategic Insights and Forecasts (2026-2035) - Product Image

Breast Cancer Diagnostics Market - Strategic Insights and Forecasts (2026-2035)

  • Report
  • 170 Pages
  • Global
From
Breast Cancer Diagnostics Market - Global Forecast 2026-2032 - Product Image

Breast Cancer Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Breast Cancer Diagnostics - Global Strategic Business Report - Product Image

Breast Cancer Diagnostics - Global Strategic Business Report

  • Report
  • 467 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.